Texas

FDA adds rare vision-loss warning to popular GLP-1 drugs

KSAT San Antonio By Matthew Perrone, Associated Press Nov 9, 2026 · 2:20 PM 2 min read 0 views 0 comments

FDA adds rare vision-loss warning to popular GLP-1 drugs — Image: KSAT San Antonio

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic.

KSAT San Antonio Original story · www.ksat.com

Read the full story

How does this story make you feel?

👍 ❤️ 💡 😮 😂 😢 😠

Discussion (0)

No comments yet. Start the conversation!

Discussion (0)

More to read

FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s

Here's how GLP-1 drugs are changing how people shop

Hormone Therapy Linked to How Some Women Respond to GLP-1 Weight Loss Drugs